Ketoconazole/Terbinafine

酮康唑/特比萘芬

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKetoconazole/Terbinafine
Drug Alias Name特比萘芬/酮康唑Ketoconazole and TerbinafineTerbinafine/KetoconazoleTerbinafine and Ketoconazole
ClassificationSmall molecules
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsSqualene monooxygenase inhibitors
TargetsLanosterol 14α-demethylaseSqualene monooxygenase
Therapy Area/IndicationsOnychomycosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes KetoconazoleTerbinafine
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaiwan Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiwan Biotech Co Ltd
Active IndicationsN/A
Inactive IndicationsOnychomycosis

Other Information

ATC CodeN/A
Related LinksN/A